πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 2,828 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8039623

Inhibitors of serine proteases, particularly HCV NS3-NS4A protease

Vertex Pharmaceuticals Incorporated Β· Granted Tue Oct 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8039661

Thiophene-carboxamides useful as inhibitors of protein kinases

Vertex Pharmaceuticals Incorporated Β· Granted Tue Oct 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8034812

Imidazopyridazine derivative having kinase inhibitory activity and pharmaceutical agent th

Takeda Pharmaceutical Company Limited Β· Granted Tue Oct 11 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8034832

Gyrase inhibitors and uses thereof

Vertex Pharmaceuticals Incorporated Β· Granted Tue Oct 11 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8034768

Composition and method for the treatment of diseases affected by histone deacetylase inhib

The Board of Regents of the University of Texas System Β· Granted Tue Oct 11 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8034821

Selective serine/threonine kinase inhibitors

The Regents of the University of California Β· Granted Tue Oct 11 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8030488

Piperazine derivatives as stearoyl-coa desaturase inhibitors and their use as therapeutic

Xenon Pharmaceuticals Inc. Β· Granted Tue Oct 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8030317

MAPK/ERK kinase inhibitors

Takeda Pharmaceutical Company Limited Β· Granted Tue Oct 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8030307

Bicyclic, C5-substituted proline derivatives as inhibitors of the hepatitis C virus NS3 pr

Enanta Pharmaceuticals, Inc. Β· Granted Tue Oct 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8026234

Polo-like kinase inhibitors

Takeda Pharmaceutical Company Limited Β· Granted Tue Sep 27 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 22 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8026360

Substituted pyridazines as stearoyl-CoA desaturase inhibitors

Xenon Pharmaceuticals Inc. Β· Granted Tue Sep 27 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 22 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8026347

Methods and compounds useful for the preparation of sodium glucose co-transporter 2 inhibi

LEXICON PHARMACEUTICALS, INC. Β· Granted Tue Sep 27 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 22 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8022057

MAPK/ERK kinase inhibitors

Takeda Pharmaceutical Company Limited Β· Granted Tue Sep 20 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8022202

Dihydrodiazepines useful as inhibitors of protein kinases

Vertex Pharmaceuticals Incorporated Β· Granted Tue Sep 20 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8022041

Prodrug of an ICE inhibitor

Vertex Pharmaceuticals Incorporated Β· Granted Tue Sep 20 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8017781

Azaindazoles useful as inhibitors of kinases

Vertex Pharmaceuticals Incorporated Β· Granted Tue Sep 13 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8017619

Compositions useful as inhibitors of protein kinases

Vertex Pharmaceuticals Incorporated Β· Granted Tue Sep 13 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8012965

Bridged bicyclic aryl and bridged bicyclic heteroaryl substituted triazoles useful as axl

Rigel Pharmaceuticals, Inc. Β· Granted Tue Sep 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8013015

Small molecule inhibitors of ghrelin O-acyltransferase

The Board of Regents of the University of Texas System Β· Granted Tue Sep 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8012976

Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP)

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue Sep 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8008510

Metalloprotein inhibitors

The Regents of the University of California Β· Granted Tue Aug 30 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 25 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7998992

Oxazolidinone derivative having inhibitory activity on 11Ξ²-hydroxysteroid dehydrogenase ty

Institute of Medicinal Molecular Design, Inc. Β· Granted Tue Aug 16 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 11 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7998987

Inhibitors of c-Met and uses thereof

Vertex Pharmaceuticals Incorporated Β· Granted Tue Aug 16 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 11 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7994326

Potent and highly selective heteroaromatic inhibitors of neuronal nitric oxide synthase

Northwestern University Β· Granted Tue Aug 09 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted